<--- Back to Details
First PageDocument Content
Clinical research / Pharmacology / Drug safety / Pharmaceutical industry / Adverse event / Institutional review board / Food and Drug Administration / National Institutes of Health / Adverse effect / Medicine / Health / Research
Date: 2014-03-10 08:07:42
Clinical research
Pharmacology
Drug safety
Pharmaceutical industry
Adverse event
Institutional review board
Food and Drug Administration
National Institutes of Health
Adverse effect
Medicine
Health
Research

SOP 16. REPORTING REQUIREMENTS FOR UNANTICIPATED PROBLEMS,

Add to Reading List

Source URL: ohsr.od.nih.gov

Download Document from Source Website

File Size: 1,09 MB

Share Document on Facebook

Similar Documents

Institutional Review Board Wake Forest University – Reynolda Campus Certificate of Confidentiality Checklist Note: A Certificate of Confidentiality will not be issued to an applicant co

DocID: 1uZkR - View Document

Institutional Review Board . ... . .

DocID: 1ubXP - View Document

University of Pennsylvania  Institutional Review Board O Is IRB Review Required? The first question one should consider when assessing the requirement for IRB review is whether the activity meets the regulatory defini

DocID: 1tsSK - View Document

Reliance Memorandum of Understanding Between and Among the University of California Campuses, UC Division of Agriculture and Natural Resources, and Lawrence Berkeley National Laboratory for Institutional Review Board Rev

DocID: 1to8J - View Document

INSTITUTIONAL REVIEW BOARD HUMAN SUBJECTS RESEARCH DETERMINATION FORM Instructions: Complete this form to help determine if your project qualifies as research that involves the use of human participants. You are not r

DocID: 1tdGE - View Document